Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

672

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Atherosclerosis
Interventions
DRUG

Glipizide

oral anti-diabetic medication

DRUG

rosiglitazone maleate

oral antidiabetic medication

Trial Locations (156)

1181

GSK Investigational Site, Capital Federal

1221

GSK Investigational Site, Buenos Aires

1405

GSK Investigational Site, Buenos Aires

1416

GSK Investigational Site, Buenos Aires

1428

GSK Investigational Site, Buenos Aires

1605

GSK Investigational Site, Munro

1650

GSK Investigational Site, San Martín

1709

GSK Investigational Site, Moron-Provincia de Buenos Aires

5000

GSK Investigational Site, Córdoba

GSK Investigational Site, Córdoba

10032

GSK Investigational Site, New York

10330

GSK Investigational Site, Bangkok

12208

GSK Investigational Site, Albany

13005

GSK Investigational Site, Marseille

15009

GSK Investigational Site, Beaver

17011

GSK Investigational Site, Camp Hill

19141

GSK Investigational Site, Philadelphia

20010

GSK Investigational Site, Washington D.C.

20089

GSK Investigational Site, Rozzano (Mi)

21044

GSK Investigational Site, Columbia

21287

GSK Investigational Site, Baltimore

27103

GSK Investigational Site, Winston-Salem

27157

GSK Investigational Site, Winston-Salem

28035

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Marid

29010

GSK Investigational Site, Málaga

30120

GSK Investigational Site, Murcia

30309

GSK Investigational Site, Atlanta

32901

GSK Investigational Site, Melbourne

33006

GSK Investigational Site, Oviedo

33100

GSK Investigational Site, Udine

33609

GSK Investigational Site, Tampa

35033

GSK Investigational Site, Rennes

35235

GSK Investigational Site, Birmingham

38301

GSK Investigational Site, Jackson

40454

GSK Investigational Site, Düsseldorf

41539

GSK Investigational Site, Dormagen

44137

GSK Investigational Site, Dortmund

44328

GSK Investigational Site, Dortmund

44339

GSK Investigational Site, Dortmund

44340

GSK Investigational Site, Guadalajara

44534

GSK Investigational Site, Lünen

44623

GSK Investigational Site, Herne

44653

GSK Investigational Site, Herne

44708

GSK Investigational Site, Canton

44789

GSK Investigational Site, Bochum

45122

GSK Investigational Site, Essen

45136

GSK Investigational Site, Essen

45309

GSK Investigational Site, Essen

45329

GSK Investigational Site, Essen

45355

GSK Investigational Site, Essen

45359

GSK Investigational Site, Essen

45772

GSK Investigational Site, Marl

45881

GSK Investigational Site, Gelsenkirchen

46049

GSK Investigational Site, Oberhausen

46260

GSK Investigational Site, Indianapolis

46537

GSK Investigational Site, Dinslaken

47119

GSK Investigational Site, Duisburg

50200

GSK Investigational Site, Chiang Mai

51377

GSK Investigational Site, Leverkusen

53215

GSK Investigational Site, Milwaukee

54292

GSK Investigational Site, Trier

54296

GSK Investigational Site, Trier

55624

GSK Investigational Site, Rhaunen

61615

GSK Investigational Site, Peoria

62702

GSK Investigational Site, Springfield

64060

GSK Investigational Site, Monterrey

65807

GSK Investigational Site, Springfield

66299

GSK Investigational Site, Friedrichsthal

66386

GSK Investigational Site, Sr. Ingbert

66740

GSK Investigational Site, Saarlouis

67063

GSK Investigational Site, Ludwigshafen am Rhein

67346

GSK Investigational Site, Speyer

68161

GSK Investigational Site, Mannheim

68623

GSK Investigational Site, Lampertheim

69120

GSK Investigational Site, Heidelberg

69126

GSK Investigational Site, Heidelberg

69434

GSK Investigational Site, Hirschhorn

78207

GSK Investigational Site, San Antonio

78229

GSK Investigational Site, San Antonio

78404

GSK Investigational Site, Corpus Christi

80113

GSK Investigational Site, Englewood

80220

GSK Investigational Site, Denver

85251

GSK Investigational Site, Scottsdale

85745

GSK Investigational Site, Tucson

90017

GSK Investigational Site, Los Angeles

90503

GSK Investigational Site, Torrance

90509

GSK Investigational Site, Torrance

91106

GSK Investigational Site, Corbeil-Essonnes

91505

GSK Investigational Site, Burbank

92350

GSK Investigational Site, Le Plessis-Robinson

92648

GSK Investigational Site, Huntington Beach

92691

GSK Investigational Site, Mission Viejo

95326

GSK Investigational Site, Kulmbach

95817

GSK Investigational Site, Sacramento

95825

GSK Investigational Site, Sacramento

96215

GSK Investigational Site, Lichtenfels

96317

GSK Investigational Site, Kronach

96450

GSK Investigational Site, Coburg

98004

GSK Investigational Site, Bellevue

110017

GSK Investigational Site, New Delhi

121552

GSK Investigational Site, Moscow

123182

GSK Investigational Site, Moscow

400005

GSK Investigational Site, Mumbai

01199

GSK Investigational Site, Springfield

08903

GSK Investigational Site, New Brunswick

C1155ADP

GSK Investigational Site, Capital Federal

C1437JCP

GSK Investigational Site, Capital Federal

B1704ETD

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

B7118XAB

GSK Investigational Site, San Justo

C1416DRW

GSK Investigational Site, Buenos Aires

14048-900

GSK Investigational Site, Ribeirão Preto

04012-909

GSK Investigational Site, São Paulo

05403-000

GSK Investigational Site, São Paulo

05651-901

GSK Investigational Site, São Paulo

L8L 2X2

GSK Investigational Site, Hamilton

N6A 4V2

GSK Investigational Site, London

M4N 3M5

GSK Investigational Site, Toronto

M5B 1W8

GSK Investigational Site, Toronto

H1T 1C8

GSK Investigational Site, Montreal

500 05

GSK Investigational Site, Hradec Králové

115 26

GSK Investigational Site, Athens

115 27

GSK Investigational Site, Athens

155 62

GSK Investigational Site, Athens

176 74

GSK Investigational Site, Athens

Unknown

GSK Investigational Site, Causeway Bay

GSK Investigational Site, Kowloon

GSK Investigational Site, Kwun Tong

GSK Investigational Site, Pokfulam

GSK Investigational Site, Shatin

LV1002

GSK Investigational Site, Riga

4818 CK

GSK Investigational Site, Breda

5623 EJ

GSK Investigational Site, Eindhoven

7511JX

GSK Investigational Site, Enschede

3435 CM

GSK Investigational Site, Nieuwegein

3015 GD

GSK Investigational Site, Rotterdam

3075 EA

GSK Investigational Site, Rotterdam

8011 JW

GSK Investigational Site, Zwolle

15-276

GSK Investigational Site, Bialystok

62-800

GSK Investigational Site, Kalisz

40-635

GSK Investigational Site, Katowice

60-355

GSK Investigational Site, Poznan

04-628

GSK Investigational Site, Warsaw

105 229

GSK Investigational Site, Moscow

110-744

GSK Investigational Site, Seoul

120-752

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

443-721

GSK Investigational Site, Suwon

03010

GSK Investigational Site, Alicante

08916

GSK Investigational Site, Badalona

08035

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona

08097

GSK Investigational Site, Barcelona

03550

GSK Investigational Site, San Juan/Alicante

SE-413 45

GSK Investigational Site, Gothenburg

SE-171 76

GSK Investigational Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00116831 - Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes | Biotech Hunter | Biotech Hunter